To explore the possibility of using this methylated SLC19A3 DNA as a marker for breast cancer detection, we developed a robust and simple methylation-sensitive restriction enzyme-based quantitative assay to measure methylated SLC19A3 DNA in plasma. This evidence concerns the gene SLC19A3 and breast cancer.